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Chronic pancreatitis (CP) is a progressive inflammatory disease in which the pancreatic
secretory parenchyma is destroyed and replaced by fibrosis. The presence of intraductal
pancreatic stone(s) is important for the diagnosis of CP; however, the precise molecular
mechanisms of pancreatic stone formation in CP were left largely unknown. Cystic fibrosis
transmembrane conductance regulator (CFTR) is a chloride channel expressed in the apical
plasma membrane of pancreatic duct cells and plays a central role in HCO−3 secretion. In
previous studies, we have found that CFTR is largely mislocalized to the cytoplasm of pan-
creatic duct cells in all forms of CP and corticosteroids normalizes the localization of CFTR to
the proper apical membrane at least in autoimmune pancreatitis. From these observations,
we could conclude that the mislocalization of CFTR is a cause of protein plug formation
in CP, subsequently resulting in pancreatic stone formation. Considering our observation
that the mislocalization of CFTR also occurs in alcoholic or idiopathic CP, it is very likely
that these pathological conditions can also be treated by corticosteroids, thereby prevent-
ing pancreatic stone formation in these patients. Further studies are definitely required to
clarify these fundamental issues.
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INTRODUCTION
Chronic pancreatitis (CP) is a progressive inflammatory disease
of the pancreas, and is characterized by pancreatic exocrine and
endocrine dysfunction resulting from tissue damage caused by
inflammation. The pancreatic exocrine gland is composed of two
types of cells, duct cells and acinar cells. Duct cells secrete fluid
and HCO−3 to neutralize gastric acid from the stomach. Aci-
nar cells secrete digestive enzymes essential for the digestion of
food. Regardless of the cause of pancreatitis, HCO−3 and digestive
enzyme secretion are more or less compromised in all forms of
chronic pancreatitis.
For a diagnosis of CP (Homma et al., 1997), it is essential to
show the inflammation and destruction of the gland; however, it
is often difficult to obtain pancreatic tissues due to the anatomy
of the gland, except in cases of a pancreatic resection for malig-
nant tumors. Another way to diagnose CP is to show exocrine
pancreatic dysfunction. Pancreatic ductal dysfunction, especially
a low HCO−3 concentration in the pancreatic juice, is the most
important finding for the diagnosis of CP with mild or moder-
ate exocrine dysfunction, since an impairment in ductal HCO−3
secretion is one of the earliest defects in CP (Freedman, 1998).
For evaluating exocrine function, the secretin test was the only
reliable test which can directly measure pancreatic ductal function
(Ko et al., 2010) and acinar cell function separately; however, it
became impossible to diagnose mild or moderate CP Functionally
because the secretin test is no longer available in Japan due to
the lack of supply of the clinical grade secretin. For that reason,
the presence of pancreatic ductal stones became the most reliable
diagnostic criterion for chronic pancreatitis.
Pancreatic stones are thought to be formed at first as pro-
tein plugs in pancreatic ducts in CP (Freedman, 1998). How-
ever, detailed molecular mechanisms of how pancreatic stones are
formed in pancreatic ducts of CP still remain elusive. In previous
studies, while elucidating the molecular mechanisms of aberrant
HCO−3 transport in pancreatic ducts in chronic pancreatitis, we
have found that the Cystic fibrosis transmembrane conductance
regulator (CFTR) chloride channel, which plays a central role in
HCO−3 transport in pancreatic ducts, is largely mislocalized in
the cytoplasm of pancreatic duct cells in autoimmune pancreatitis
(Ko et al., 2010). As the cytoplasmic mislocalization of CFTR has
been observed in all other forms of CP (i.e., alcoholic, idiopathic,
or obstructive), we concluded that the mislocalization of CFTR
is a cause of pancreatic ductal dysfunction and subsequent pan-
creatic stone formation. This notion was further supported by the
observation that corticosteroids, a potent anti-inflammatory drug,
normalize the CFTR localization from the cytoplasm of pancreatic
duct cells to the proper apical plasma membrane, and subsequently
restored aberrant pancreatic HCO−3 secretion.
In this article, we propose that the cytoplasmic mislocaliza-
tion of the CFTR in pancreatic duct cells is a cause of pancreatic
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FIGURE 1 | Pancreatic exocrine functions are compromised in chronic
pancreatitis. Pancreatic exocrine functions of patients with alcoholic chronic
pancreatitis were evaluated by a canonical secretin-stimulated exocrine
function test. Pancreatic fluid volume (lower limit of normal, 183 ml/h),
maximum bicarbonate (HCO−3 ) concentration in pancreatic juice (MBC: lower
limit of normal, 80 mEq/l), and total amylase output (AO: lower limit of normal,
99,000 U/h), were all impaired in most of the patients with chronic
pancreatitis (Ko et al., 2010).
stone formation in chronic pancreatitis. Currently, steroid treat-
ment for autoimmune pancreatitis is the only established ther-
apy to restore impaired pancreatic ductal function. It might be
possible that pancreatic ductal dysfunction seen in alcoholic or
idiopathic pancreatitis can also be cured by the administration of
corticosteroid treatment. Further studies are definitely required
to clarify these important issues in the treatment of chronic
pancreatitis.
HCO−3 SECRETION FROM PANCREATIC DUCT CELLS IS
COMPROMISED IN CHRONIC PANCREATITIS
The normal pancreas secretes the most alkaline fluid among
exocrine organs in humans (maximum HCO−3 concentration in
pancreatic juice around 140 mM, pH∼8.5) to neutralize acid from
the stomach (Steward et al., 2005). In pancreatic ducts in chronic
pancreatitis, it is well known that the alkalinization of pancre-
atic juice is impaired, and results in a low pH in secreted fluid.
However, the precise molecular mechanisms of pancreatic ductal
dysfunction remained elusive.
Figure 1 shows pancreatic exocrine functions in patients with
alcoholic chronic pancreatitis. Pancreatic fluid volume (V: lower
limit of normal, 183 ml/h), maximum bicarbonate concentration
(MBC) in pancreatic juice (lower limit of normal, 80 mEq/l), and
total amylase output (AO: lower limit of normal, 99,000 U/h),
were all impaired in alcoholic chronic pancreatitis. In a severe
form of chronic pancreatitis, all three factors are impaired. In
some cases with mild or moderate forms of chronic pancreatitis,
fluid volume, and AO may stay within normal range; however,
HCO−3 secretion is frequently impaired even in a mild form of
the disease. Therefore direct measurement of maximum HCO−3
concentration in pancreatic juice was very valuable to diag-
nose mild or moderate forms of CP when the secretin test was
available.
MOLECULAR MECHANISM OF PANCREATIC HCO−3
SECRETION FROM THE NORMAL DUCT CELLS
The pancreatic duct epithelium is capable of secreting HCO−3 at
a concentration of around 140 mM (Steward et al., 2005). Mole-
cular mechanisms of how the pancreatic duct epithelium secretes
such a high concentration of HCO−3 have long been examined
(Figure 2). A primary fluid rich in digestive enzymes secreted
from pancreatic acinar cells contains around 24 mM HCO−3 . The
digestive hormone secretin was secreted from the endocrine cells
in the duodenum when these cells were stimulated with gastric acid
from the stomach. Secretin binds to its receptor on the basolateral
membrane of pancreatic duct cells. An increase of intracellular
cyclic AMP levels stimulates the CFTR chloride channel which is
located at the apical plasma membrane of small pancreatic duct
cells. Cl− ions pass through the CFTR chloride channel into the
luminal space of pancreatic ducts. HCO−3 was secreted from pan-
creatic duct cells in exchange for Cl− absorption by an electrogenic
anion exchanger, SLC26 transporters, expressed also at the apical
plasma membrane of pancreatic ducts (Ko et al., 2002, 2004; Song
et al., 2012). When Cl− concentration in the juice becomes quite
low, HCO−3 was secreted to the luminal space of pancreatic ducts
through CFTR chloride channels (Ishiguro et al., 2009).
CFTR CHLORIDE CHANNEL IS MISLOCALIZED TO THE
CYTOPLASM OF PANCREATIC DUCTS IN CHRONIC
PANCREATITIS
It has been well known that the HCO−3 concentration in pancreatic
juice is reduced in CP (Braganza et al., 2011). In previous studies,
however, it was unclear why HCO−3 concentration in pancreatic
juice in CP is low. It has been shown that the CFTR plays a most
pivotal role in HCO−3 secretion in pancreatic duct cells. Thus, it is
reasonable to consider whether or not the expression of CFTR is
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FIGURE 2 | Cellular mechanism proposed for ion and fluid secretion by
the pancreatic duct epithelium. The primary fluid secreted by acinar cells
contains a large amount of digestive enzymes and 24 mM HCO−3 .
Intracellular HCO−3 leaves the cell in exchange for Cl
−, mediated by SLC26
anion exchangers. Cl− is supplied to the lumen by a secretin-stimulated Cl−
channel, the Cystic fibrosis transmembrane conductance regulator (CFTR).
For fluid movement across the epithelium, aquaporin (AQP) water channels
are present at both the apical and basolateral membranes of smaller ducts
in the rat (Furuya et al., 2002) and human pancreas (Burghardt et al., 2003).
PKA, protein kinase A; pNBC1, pancreatic sodium bicarbonate
cotransporter1; NHE1, sodium proton exchanger1.
compromised in pancreatic duct cells in patients with chronic pan-
creatitis. To this end, we have examined the immunolocalization
of the CFTR in these patients. In the normal pancreas the CFTR
is expressed exclusively at the plasma membrane of small pancre-
atic ducts (Figure 3). However, in chronic pancreatitis, trafficking
of the CFTR is largely compromised and the protein is largely
retained at the cytoplasm of pancreatic ducts (Figure 3). CFTR
plays a central role in HCO−3 secretion from pancreatic duct cells;
therefore, the reduced CFTR expression at the apical membrane
of pancreatic ducts should result in the low HCO−3 concentration
seen in CP (Ko et al., 2011).
STEROID THERAPY NORMALIZES CYTOPLASMIC
MISLOCALIZATION OF CFTR TO THE APICAL PLASMA
MEMBRANE OF PANCREATIC DUCT CELLS IN AUTOIMMUNE
PANCREATITIS AND RECOVERS ABERRANT HCO−3
SECRETION IN CHRONIC PANCREATITIS
Autoimmune pancreatitis is one form of chronic pancreatitis.
Autoimmunity is suspected to be its pathogenesis (Yoshida et al.,
1995). Severe exocrine insufficiency has been reported in most of
the cases (Ito et al., 2007; Frulloni et al., 2010; Ko et al., 2010).
Steroid therapy improves the swelling of the gland and narrowing
of the main pancreatic ducts, and reduces serum gamma globulin
and immunoglobulin G subtype 4 (IgG4) levels.
To further elucidate the role of CFTR mislocalization in the
aberrant ductal HCO−3 secretion in chronic pancreatitis, we have
examined histology (Mizuno et al., 2009) and exocrine functions
of patients with autoimmune pancreatitis at the diagnosis and
3 months after maintenance steroid treatment (Ko et al., 2010).
In autoimmune pancreatitis, HCO−3 concentration in pancre-
atic juice is remarkably reduced prior to treatment as well as
in other forms of CP (Figure 4), whereas 3 months of steroid
therapy restored the mislocalization of the CFTR to the proper
apical plasma membrane and significantly improved the HCO−3
FIGURE 3 | Immnolocalization of CFTR in the pancreas of normal and
chronic pancreatitis. In the normal subjects, the CFTR chloride channel is
exclusively localized in the apical plasma membrane of small pancreatic
ducts (left panel). In contrast, the CFTR chloride channel is largely retained
at the cytoplasm of pancreatic ducts and is not transported to the proper
apical plasma membrane domain in alcoholic chronic pancreatitis (right
panel; modified from Freedman, 1998).
FIGURE 4 | Effects of corticosteroids on the localization of CFTR and
pancreatic ductal dysfunction in autoimmune pancreatitis. The lower
panel shows the changes in HCO−3 concentrations in the pancreatic juice of
autoimmune pancreatitis treated by corticosteroids. The HCO−3
concentration in pancreatic juice is quite low prior to treatment. However,
3 months of corticosteroid treatment significantly increased HCO−3
concentration in the pancreatic juice in autoimmune pancreatitis. The upper
panel shows the changes of immunolocalization of the CFTR in human
pancreatic ducts (modified from Freedman, 1998). Much of the CFTR
proteins were retained at the cytoplasm of small pancreatic ducts and were
not transported to the proper apical plasma membrane domain (left). Three
months of corticosteroid treatment completely corrected the localization of
the CFTR from the cytoplasm of pancreatic ducts to the apical membrane
(right).
concentration in pancreatic juice (Figure 4). These data indi-
cate that the mislocalization of the CFTR is a direct cause of
a low HCO−3 concentration in pancreatic juice and that steroid
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treatment restores both the localization of CFTR and HCO−3
concentration in pancreatic juice in autoimmune pancreatitis.
PANCREATIC DUCTAL DYSFUNCTION IS NOT RECOVERED
SPONTANEOUSLY IN CHRONIC ALCOHOLIC PANCREATITIS
We have shown that the mislocalization of the CFTR in the
cytoplasm of pancreatic ducts is a possible cause of the low
FIGURE 5 | HCO−3 secretory defect is not spontaneously recovered in
alcoholic pancreatitis. The secretin-stimulated pancreatic exocrine test
shows that a 1-year interval does not affect the HCO−3 secretory defect in
alcoholic chronic pancreatitis.
HCO−3 concentration found in pancreatic juice in chronic pan-
creatitis. If this proposed molecular mechanism is correct, one
would speculate that the retargeting of the CFTR at the apical
plasma membrane by the specific anti-inflammatory treatment
will restore pancreatic HCO−3 secretion in chronic pancreatitis,
and prevent pancreatic stone formation in chronic pancreatitis.
Thus, we next examined HCO−3 concentrations in the juice of 18
cases of chronic alcoholic pancreatitis to see if pancreatic duc-
tal dysfunction spontaneously recovers (Figure 5). As shown in
Figure 5, a 1-year observation period did not affect the HCO−3
concentrations of pancreatic juice in chronic alcoholic pancreati-
tis without an active anti-inflammatory regimen, indicating that
pancreatic ductal dysfunction does not improve spontaneously in
chronic pancreatitis.
PROPOSED MOLECULAR MECHANISM OF PANCREATIC
STONE FORMATION IN CHRONIC PANCREATITIS
Figure 6 shows the possible steps/mechanisms for pancreatic stone
formation in chronic pancreatitis.
Step 1: Chronic inflammation occurred in the pancreas by
drinking, gallstone, or autoimmune mechanisms.
Step 2: Trafficking of membrane proteins such as the CFTR is
compromised and the proteins are mislocalized to the cytoplasm
of pancreatic ducts.
Step 3: Decrease of the CFTR expression at the plasma membrane
results in a low HCO−3 concentration in pancreatic juice.
Step 4: Decrease of HCO−3 secretion further decreases the pH
and volume of the fluid secreted by pancreatic ducts.
Step 5: Low fluid volume can result in the precipitation of diges-
tive enzymes in pancreatic fluid and protein plugs are formed in
pancreatic ducts in chronic pancreatitis.
FIGURE 6 | Proposed cellular mechanisms of pancreatic stone formation in chronic pancreatitis.
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Step 6: Protein plugs formed in pancreatic ducts disturb pancre-
atic juice outflow and protein plugs are calcified.
Step 7: Protein plugs and pancreatic stones obstruct pancreatic
juice flow further and cause obstructive/upstream pancreatitis.
Obstructive pancreatitis caused by protein plugs and stones in
pancreatic ducts exacerbate the cytoplasmic mislocalization of
CFTR, and then compromise pancreatic ductal dysfunction.
CONCLUSIONS
Extensive research has revealed the molecular mechanisms of ion
and fluid secretion in the physiological and pathological status
(chronic pancreatitis) of the pancreas. Cytoplasmic mislocaliza-
tion of the CFTR chloride channel results in aberrant HCO−3 secre-
tion from the pancreatic ducts in chronic pancreatitis. Nonethe-
less, there is no cure for pancreatic ductal dysfunction in CP such
as alcoholic or idiopathic pancreatitis. However, we have found for
the first time that pancreatic ductal dysfunction of patients with
autoimmune pancreatitis was partially reversed by the corticos-
teroid treatment. Further investigation to examine the effects of
an anti-inflammatory regimen on pancreatic ductal dysfunction
in other forms of Cp should eventually lead to the establishment
of the treatment for chronic pancreatitis.
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